PCR Role in Screening & Diagnostics Discussed by Biopharm Reports in New Market Study Available at MarketPublishers.com

  PCR Role in Screening & Diagnostics Discussed by Biopharm Reports in New
  Market Study Available at MarketPublishers.com

Business Wire

LONDON -- June 3, 2013

Polymerase chain reaction (PCR) technology is widely utilised in the molecular
biology field, including a variety of applications such as sequencing, DNA
fingerprinting, cloning, infectious diseases molecular testing, research, drug
RnD, disease biomarkers, gene expression, forensics, among others. The
technique’s growing popularity is expected to drive the global market to a
value of USD27bn by end-2015. Furthermore, a constant rise in the number of
patients afflicted with cancer, AIDS and hepatitis, as well as huge
investments into medical research also contribute to the market expansion.

Different PCR techniques available in the market today include reverse
transcription PCR (RTPCR), quantitative PCR (qPCR), inverse PCR, assembly PCR
(polymerase cycling assembly, PCA), allele specific PCR, multiplex PCR,
taqman, nested PCR, among others. Abbott Laboratories, Agilent Technologies,
Beckman Coulter Inc., Affymetrix Inc., Roche, Sigma-Aldrich Corp., Becton,
Dickinson and Co. (BD), and GE Healthcare are some of the dominant players in
the world PCR field.

New market study  “PCR in Screening and Diagnostics: Market Developments,
Growth Areas and Opportunities”  created by Biopharm Reports examines the use
of PCR in screening and diagnostics worldwide. The report investigates key
market developments, and identifies new insights and opportunities in the
marketplace during 2013-2016. In particular, it analyses current and future
anticipatedtechniques and applications, end-users’ plans for using PCR in
screening and diagnostics in the forecast period, as well as preferred
products, purchasing and new developments. Additionally, the research covers
new and emerging applications, end-users’ preferred PCR instruments and their
strengths and weaknesses, current and future expenditure and financial 
budgets, budget breakdown, average costs per sample, innovation, quality
control guidelines or procedures used in PCR analysis, consumables,
bioinformatics software, and sample preparation.

Report Details:

Title: PCR in Screening and Diagnostics: Market Developments, Growth Areas and
Opportunities
Published: June, 2013
Pages: 168
Price: US$ 2,794.00
http://marketpublishers.com/report/life_sciences/healthcare/pcr-in-screening-n-diagnostics-market-developments-growth-areas-n-opportunities.html

Report Contents:

CHAPTER 1 INTRODUCTION

CHAPTER 2 STUDY PARTICIPANTS

2.1 This Chapter

2.2 Countries

2.3 Regions

2.4 Organisation Types

2.5 Fields

2.6 PCR Activities

2.7 Participants

2.8 Discussion

Figure 2.1 Countries of individuals who participated in PCR 2013 CLIN

...

More new studies by Biopharm Reports can be found at
http://marketpublishers.com/members/biopharm_reports/info.html

Contact:

The Market Publishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970
ps@marketpublishers.com
MarketPublishers.com
 
Press spacebar to pause and continue. Press esc to stop.